IceCure Medical (ICCM) Net Cash Flow (2020 - 2026)

IceCure Medical (ICCM) has 7 years of Net Cash Flow data on file, last reported at -$785000.0 in Q1 2026.

• On a quarterly basis, Net Cash Flow rose 47.03% year-over-year to -$785000.0 in Q1 2026; TTM through Mar 2026 was $1.9 million, a 139.3% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 141.77% from the prior year.
• Net Cash Flow for Q1 2026 stood at -$785000.0, down from $3.7 million in the prior quarter.
• Over the last five years, Net Cash Flow for ICCM reached as high as $11.1 million in Q4 2022 and fell as low as -$18.1 million in Q1 2023.
• Historically, Net Cash Flow has averaged -$1.0 million across 5 years, with a median of -$785000.0 in 2026.
• Across the five-year window, Net Cash Flow plunged 463.58% in 2023 and surged 219.19% in 2025, its largest moves.
• Year by year, Net Cash Flow stood at $11.1 million in 2022, then slumped by 41.76% to $6.5 million in 2023, then tumbled by 147.86% to -$3.1 million in 2024, then jumped by 219.19% to $3.7 million in 2025, then tumbled by 121.24% to -$785000.0 in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were -$785000.0 in Q1 2026, $3.7 million in Q4 2025, and -$241000.0 in Q3 2025.